Here we showed significant higher expression of B3GALT5 in TNBC subtype of breast cancer tissues and provided the first evidence for the poor prognostic significance of B3GALT5 expression in early stage breast cancer. This evidence concerns the gene B3GALT5 and breast carcinoma.